MGMT and neoplasm: We have demonstrated that NEO412 exhibited its cytotoxicity against melanoma cells in vivo when the agent is applied to the skin directly above the tumor as well as at distant sites and the agent is effective in a dose dependent manner in TMZ resistant cells (MGMT positive).